Cosmetics News and Research

RSS

New treatment for adults with rare, life-threatening blood disease receives FDA approval

The U.S. Food and Drug Administration today approved Ultomiris (ravulizumab) injection for the treatment of adult patients with paroxysmal nocturnal hemoglobinuria (PNH), a rare and life-threatening blood disease.

21 Dec 2018

FDA approves new treatment for rare disease of the bone marrow and blood

The U.S. Food and Drug Administration today approved Elzonris (tagraxofusp-erzs) infusion for the treatment of blastic plasmacytoid dendritic cell neoplasm in adults and in pediatric patients, two years of age and older.

21 Dec 2018

FDA warns against use of jewelry to relieve teething pain in children

Today, the U.S. Food and Drug Administration alerted parents, caregivers and health care providers to the safety risks that jewelry used for relieving teething pain pose for children.

21 Dec 2018

FDA warns Genetech for marketing stem cell products without approval

The U.S. Food and Drug Administration has warned Genetech, Inc. of San Diego, California and its president, Edwin N. Pinos for marketing stem cell products without FDA approval and for significant deviations from current good tissue practice and current good manufacturing practice requirements, including some violations that may have led to microbial contamination, potentially causing serious blood infections in patients.

20 Dec 2018

Michigan-based food manufacturer ordered to discontinue operations after recurrent food safety violations

A federal court ordered a Michigan-based food manufacturer to discontinue selling food products until the company complies with federal regulations and other requirements.

18 Dec 2018

A Story of Innovative Molecules: From Machines to Cyclic Compounds

2016 Nobel Laureate in Chemistry Fraser Stoddart outlines his research involving mechanically interlocked molecules and molecular machines, and introduces the work of some of the students in his lab, to be discussed at Pittcon 2018.

From Pittcon 17 Dec 2018

FDA issues warning letter to Zhejiang Huahai Pharmaceutical involved in valsartan recall

The U.S. Food and Drug Administration today released a warning letter issued to Zhejiang Huahai Pharmaceutical Co. Ltd. (ZHP), in Linhai, Taizhou Zhejiang China, the manufacturer of the active pharmaceutical ingredient (API) found in valsartan that is the subject of an ongoing FDA investigation into probable cancer-causing impurities in certain commonly prescribed heart medicines.

12 Dec 2018

FDA clears mobile medical app to help increase retention in recovery program for opioid use disorder

Today, the U.S. Food and Drug Administration cleared a mobile medical application (app) to help increase retention (the amount of time a patient participates) in an outpatient treatment program for individuals with opioid use disorder.

10 Dec 2018

Researchers develop biotechnological tool to produce antifungal proteins in plants

Researchers from the Spanish Research Council at the Centre for Research in Agricultural Genomics and the Institute for Plant Molecular and Cellular Biology, in collaboration with the IATA, have developed a biotechnological tool to produce, in a very efficient manner, antifungal proteins in plants.

10 Dec 2018

Researchers report novel findings on plant hormone

Jasmonic acid is not just the aromatic odor of the plant Jasminum grandiflorum used in cosmetics and perfume industries. Plants wounded by e.g. chewing herbivores produce jasmonic acid as a defense signal, as a phytohormone to mount their defense responses - this includes for example the formation of toxic substances.

10 Dec 2018

Study addresses continued challenges of lead poisoning prevention

Over the years, the Centers for Disease Control and its partners have made major progress towards reducing lead exposure in the United States. But more work remains in preventing lead poisoning in US children and adults, according to a special supplement to the Journal of Public Health Management and Practice. The journal is published in the Lippincott portfolio by Wolters Kluwer.

5 Dec 2018

FDA approves new drug for treatment of rare autoimmune disorder

The U.S. Food and Drug Administration today approved Firdapse (amifampridine) tablets for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults.

29 Nov 2018

First biosimilar approved by FDA for treatment of adult patients with non-Hodgkin’s lymphoma

The U.S. Food and Drug Administration today approved Truxima (rituximab-abbs) as the first biosimilar to Rituxan (rituximab) for the treatment of adult patients with CD20-positive, B-cell non-Hodgkin's lymphoma (NHL) to be used as a single agent or in combination with chemotherapy.

29 Nov 2018

FDA grants accelerated approval to oncology drug for treatment of key genetic driver of cancer

The U.S. Food and Drug Administration today granted accelerated approval to Vitrakvi (larotrectinib), a treatment for adult and pediatric patients whose cancers have a specific genetic feature (biomarker).

27 Nov 2018

Nonprofit bets Asian-American students can learn to avoid unhealthy gambling

The students listened attentively as Ryan Wong explained how casinos keep customers chasing that elusive jackpot.

26 Nov 2018

FDA approves new treatment for AML patients

The U.S. Food and Drug Administration today approved Daurismo (glasdegib) tablets to be used in combination with low-dose cytarabine (LDAC), a type of chemotherapy, for the treatment of newly-diagnosed acute myeloid leukemia (AML) in adults who are 75 years of age or older or who have other chronic health conditions or diseases (comorbidities) that may preclude the use of intensive chemotherapy.

22 Nov 2018

FDA approves antibacterial drug to treat travelers' diarrhea

The U.S. Food and Drug Administration today approved Aemcolo (rifamycin), an antibacterial drug indicated for the treatment of adult patients with travelers' diarrhea caused by noninvasive strains of Escherichia coli (E. coli), not complicated by fever or blood in the stool.

17 Nov 2018

New first-line treatment for peripheral T-cell lymphoma approved by FDA

The U.S. Food and Drug Administration today expanded the approved use of Adcetris (brentuximab vedotin) injection in combination with chemotherapy for adult patients with certain types of peripheral T-cell lymphoma.

16 Nov 2018

FDA warns against use of unapproved pain medications with implanted pumps

The U.S. Food and Drug Administration today alerted health care providers and patients about the serious complications that can occur when using medications not approved for use with implanted pumps that deliver medication into the spinal fluid to treat or manage pain.

15 Nov 2018

First fully personalized tissue implant engineered from patient's own materials and cells

In a new study, Tel Aviv University researchers reveal how they invented the first fully personalized tissue implant, engineered from a patient's own materials and cells. The new technology makes it possible to engineer any kind of tissue implant from one small fatty tissue biopsy.

13 Nov 2018

Cosmetics News and Research

New treatment for adults with rare, life-threatening blood disease receives FDA approval

FDA approves new treatment for rare disease of the bone marrow and blood

FDA warns against use of jewelry to relieve teething pain in children

FDA warns Genetech for marketing stem cell products without approval

Michigan-based food manufacturer ordered to discontinue operations after recurrent food safety violations

A Story of Innovative Molecules: From Machines to Cyclic Compounds

FDA issues warning letter to Zhejiang Huahai Pharmaceutical involved in valsartan recall

FDA clears mobile medical app to help increase retention in recovery program for opioid use disorder

Researchers develop biotechnological tool to produce antifungal proteins in plants

Researchers report novel findings on plant hormone

Study addresses continued challenges of lead poisoning prevention

FDA approves new drug for treatment of rare autoimmune disorder

First biosimilar approved by FDA for treatment of adult patients with non-Hodgkin’s lymphoma

FDA grants accelerated approval to oncology drug for treatment of key genetic driver of cancer

Nonprofit bets Asian-American students can learn to avoid unhealthy gambling

FDA approves new treatment for AML patients

FDA approves antibacterial drug to treat travelers' diarrhea

New first-line treatment for peripheral T-cell lymphoma approved by FDA

FDA warns against use of unapproved pain medications with implanted pumps

First fully personalized tissue implant engineered from patient's own materials and cells

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News